A5003133082- Opioid Use Disorder Treatment
- Substance Abuse Treatment and Outcomes
- Prenatal Substance Exposure Effects
- HIV, Drug Use, Sexual Risk
- Homelessness and Social Issues
- Adolescent and Pediatric Healthcare
- Poisoning and overdose treatments
- Pain Management and Opioid Use
- Cannabis and Cannabinoid Research
- Pediatric Pain Management Techniques
- Child and Adolescent Psychosocial and Emotional Development
- Cardiac Arrest and Resuscitation
- HIV/AIDS Research and Interventions
- Suicide and Self-Harm Studies
- Alcohol Consumption and Health Effects
- Forensic Toxicology and Drug Analysis
- Smoking Behavior and Cessation
- Pharmaceutical industry and healthcare
- Pharmaceutical Economics and Policy
- Child and Adolescent Health
- Attention Deficit Hyperactivity Disorder
- LGBTQ Health, Identity, and Policy
- Mental Health Treatment and Access
- Child Abuse and Trauma
- Sexuality, Behavior, and Technology
Harvard University
2013-2025
Massachusetts General Hospital
2021-2025
Boston University
2014-2024
Boston Medical Center
2011-2024
Boston Children's Hospital
2010-2024
University of British Columbia
2024
Randolph Health
2024
John Brown University
2024
Johns Hopkins University
2008-2024
Rhode Island Department of Health
2024
Opioid use disorder (OUD) frequently begins in adolescence and young adulthood. Intervening early with pharmacotherapy is recommended by major professional organizations. No prior national studies have examined the extent to which adolescents adults (collectively termed youth) OUD receive pharmacotherapy.To identify time trends disparities receipt of buprenorphine naltrexone among youth United States.A retrospective cohort study was conducted using deidentified data from a commercial...
<h3>Importance</h3> Treatment with methadone or buprenorphine is the current standard of care for opioid use disorder. Given paucity research identifying which patients will respond best to medication, both medications should be accessible all so that can determine works them. However, given differences in historical contexts their initial implementation, access each these may vary along racial/ethnic lines. <h3>Objective</h3> To examine extent capacity provide and measures segregation....
<h3>Importance</h3> Prescription opioids are involved in 40% of all deaths from opioid overdose the United States and commonly first encountered by individuals with use disorder. It is unclear whether pharmaceutical industry marketing to physicians associated mortality overdoses. <h3>Objective</h3> To identify association between direct-to-physician products companies prescription overdoses across US counties. <h3>Design, Setting, Participants</h3> This population-based, county-level...
Retention in addiction treatment is associated with reduced mortality for individuals opioid use disorder (OUD). Although clinical trials support of OUD medications among youths (adolescents and young adults), data on timely receipt buprenorphine hydrochloride, naltrexone methadone hydrochloride its association retention care real-world settings are lacking.
Audio Interview with Joseph Friedman on increases in drug-related mortality among adolescents and approaches to overdose prevention. 10m 23s Download AbstractDrug-overdose deaths have increased recent years. Steps can be taken equip the knowledge tools they need keep themselves safe.
Adam L. Ackerman, MD; Patrick G. O'Connor, MD, MPH; Deirdre Doyle, MSN, MHA; Sheyla M. Marranca, MS; Carolyn Haight, BSN; Christine E. Day, BS; Robert Fogerty, MPH
Synthetic opioid overdose mortality among young adults has risen more than 300% in the USA since 2013, primarily due to contamination of heroin and other drugs with illicitly manufactured fentanyl. Rapid test strips, which can be used detect presence fentanyl drug samples (before use) or urine (after use), may help inform people about their exposure risk. The purpose this study was determine whether who use were willing rapid strips as a harm reduction intervention prevent overdose. We...
Collaborative on Countering the US Opioid Epidemic [8] has been focusing comprehensive and collaborative efforts to fundamentally address opioid epidemic crisis.All of these major initiatives emphasize pain education as a key component in fight against dual crises chronic epidemic.I am honored represent AAPM HHS Pain Management Task Force NAM Action contribute important our nation your behalf.The emphasizes strategic priority its mission.In coming years, we will focus defining competencies...
Nonfatal opioid overdose may be a critical touch point when youths who have never received diagnosis of use disorder can engaged in treatment. However, the extent to which (adolescents and young adults) receive timely evidence-based treatment following is unknown.
Opioid-related overdose deaths have risen sharply among young adults. Despite this increase, access to evidence-based medication for opioid agonist treatment (OAT) youth remains low. Among older adults, barriers OAT include the paucity of buprenorphine-waivered prescribers and low rates prescribing waivered physicians. We increasingly found in our clinical practice significant stigma related using treat addiction In series, we describe three cases adults who faced their treatment. The first...
From 1999 to 2016, opioid-related mortality among adolescents and young adults aged 13 25 years (referred as youth) increased 3-fold. 1 Opioid overdose deaths in adult populations often involve other substances, particularly benzodiazepines and, increasingly, stimulants. 2,3 Little is known about polysubstance involvement opioid youth.In this cross-sectional study, we examined national trends polysubstance-involved youth the US.
<h3>Importance</h3> Prescription opioids are involved in more than half of opioid overdoses among younger persons. Understanding prescribing practices is essential for developing appropriate interventions this population. <h3>Objective</h3> To examine temporal trends children, adolescents, and adults the US from 2006 to 2018. <h3>Design, Setting, Participants</h3> A population-based, cross-sectional analysis prescription data was conducted January 1, 2006, December 31, Longitudinal on retail...
This study surveyed US adolescent residential addiction treatment facilities to assess treatments used for adolescents younger than 18 years seeking opioid use disorder.
Drug overdose deaths among adolescents are increasing in the United States. Residential treatment facilities one option for with substance use disorders, yet little is known about their accessibility or cost. Using Substance Abuse and Mental Health Services Administration's locator search engine advertising data, we identified 160 residential addiction that treated opioid disorder as of December 2022. We called while role-playing aunt uncle a sixteen-year-old child recent nonfatal overdose,...